市場調查報告書
商品編碼
1466593
數位 PCR 市場:按產品類型、技術、應用和最終用戶分類 - 2024-2030 年全球預測Digital PCR Market by Product Type (Instruments, Reagents and Consumables, Services), Technology (BEAMing Digital PCR, Droplet Digital PCR), Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年數位PCR市場規模為56.4億美元,預計2024年將達62億美元,2030年將達112.5億美元,複合年成長率為10.35%。
數位 PCR (dPCR) 是一種先進的分子生物學方法,用於對核酸進行絕對定量,涉及將樣本細分為許多包含零個或一個模板分子的單獨小反應。這種分類允許對核酸豐度進行離散測量,使 dPCR 成為檢測稀有序列、量化突變和執行絕對定量的強大工具,而無需標準曲線。與qPCR技術相比,dPCR市場的成長主要是由於其卓越的準確性、敏感度和特異性,在臨床診斷、個人化醫療和突變檢測中發揮重要作用。此外,癌症研究、感染疾病診斷和作物檢測對遺傳物質精確定量的需求不斷成長,正在推動 dPCR 應用的擴展。但由於dPCR設備及相關耗材成本較高,小型實驗室及研究機構可能不願意採用。此外,該技術複雜,需要熟練的人員,這增加了營運成本,並對市場成長構成挑戰。然而,dPCR 技術與用於基因型鑒定和突變檢測的 CRISPR 應用的整合提供了巨大的成長機會。
主要市場統計 | |
---|---|
基準年[2023] | 56.4億美元 |
預計年份 [2024] | 62億美元 |
預測年份 [2030] | 112.5億美元 |
複合年成長率(%) | 10.35% |
產品類型對高通量、精密定量設備的需求不斷增加
數位PCR 市場的設備部分包括將樣本分割成數千至數百萬個液滴,對每個液滴進行PCR,然後分析這些液滴以確定遺傳物質的存在和數量,包括專為這些液滴設計的分析儀、PCR 設備和熱迴圈儀。這些儀器對於需要高靈敏度的應用至關重要,例如檢測稀有等位基因、量化病毒量和檢驗次世代定序儀資料。試劑和耗材對於確保數位 PCR 實驗的效率、可靠性和重現性至關重要。此類別包括廣泛的產品,包括預混液、螢光標記探針和專用針對數位 PCR 最佳化的引子。此外,微孔盤、晶片和卡盒等消耗品設計為一次性使用,以防止交叉污染。數位 PCR 服務部門為缺乏內部執行數位 PCR 的資源或專業知識的研究人員和實驗室提供從實驗設計到資料分析的全面支援。這些服務包括測定設計、樣品製備和自訂分析。
應用 dPCR 在疾病檢測與監測的重要性
在臨床研究中,dPCR 主要因其定量準確度高、靈敏度高以及檢測低水平病原體、微小殘留疾病和基因突變的能力而被採用。 dPCR 的可靠性對於液態切片、感染疾病檢測和腫瘤學研究至關重要。傳染病檢查中的 dPCR 提供了一種檢測和量化傳染性病原體的可靠方法,確保及時、準確地診斷病毒和細菌感染。在腫瘤學檢測中,dPCR 能夠檢測與癌症相關的突變並定量血液中的腫瘤 DNA,為癌症診斷和治療決策提供寶貴的見解。在移植診斷領域,dPCR有助於準確監測移植受者血液中的供體器官DNA,對於移植排斥的早期檢測和指南免疫抑制治療具有重要意義。
數位 PCR 由於其在水、土壤和空氣樣本中特定微生物和病毒病原體檢測和定量方面的高精度而在環境監測中得到重要應用。 dPCR 能夠在無需事先孵育的情況下分析複雜的環境樣本,並將自己定位為監測水質、空氣傳播的病原體和土壤健康的重要工具。數位PCR廣泛應用於基因作物(GMO)檢測,因為它可以高精度地檢測和量化作物和食品中的基因改造序列。高靈敏度可以準確測定基因改造生物含量,這對於標籤合規性和消費者安全至關重要。
區域洞察
在美洲,強大的研究基礎設施、大型製藥和生物技術公司的存在以及對醫療保健和診斷的大量投資主要推動了數位 PCR 技術的採用和實施。對腫瘤學研究的投資和對感染疾病診斷的關注進一步推動了該地區對 dPCR 的需求,從而導致全球市場顯著成長。歐洲、中東和非洲地區的市場引進多種多樣,因為每個國家都有不同的經濟實力、技術力和醫療保健系統。由於製藥和生物技術研究領域的進步,加上支持基因組研究的政府政策,歐洲的採用率很高。中東和非洲正在成長,但普及緩慢,很大程度上受到基礎設施和資金有限的阻礙。然而,醫療保健投資的增加以及對先進診斷解決方案意識的提高預計將推動這些地區 dPCR 市場的成長。由於醫療保健基礎設施的快速開拓、生物技術和藥物研究投資的增加以及對精準醫療的興趣日益濃厚,亞太地區的 dPCR 市場成長最快。此外,人口成長和慢性病盛行率上升導致採用先進的診斷技術,包括 dPCR。
FPNV定位矩陣
FPNV定位矩陣對於評估數位PCR市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對數位 PCR 市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1. 數位PCR市場規模及預測是多少?
2.數位PCR市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3.數位PCR市場的技術趨勢和法規結構是什麼?
4.數位PCR市場主要廠商的市場佔有率是多少?
5.進入數位PCR市場合適的型態和策略手段是什麼?
[180 Pages Report] The Digital PCR Market size was estimated at USD 5.64 billion in 2023 and expected to reach USD 6.20 billion in 2024, at a CAGR 10.35% to reach USD 11.25 billion by 2030.
Digital PCR (dPCR) is an advanced molecular biology technique for the absolute quantification of nucleic acids, which includes subdividing the sample into many individual, smaller reactions that contain either zero or one template molecule. This partitioning allows for discrete measurement of nucleic acid amounts, making dPCR a powerful tool for detecting rare sequences, quantifying mutations, and providing absolute quantification without the need for standard curves. The growth of the dPCR market is primarily driven by its superior accuracy, sensitivity, and specificity compared to qPCR technologies, making it important for clinical diagnostics, personalized medicine, and mutation detection. Additionally, the rising demand for precise quantification of genetic materials for cancer research, infectious disease diagnosis, and GMO detection fuels the expansion of dPCR applications. However, the high cost of dPCR instruments and related consumables can deter small laboratories or research institutions from its adoption. The complexity of the technology also requires skilled personnel, adding to operational costs and posing challenges to market growth. However, the integration of dPCR technologies with CRISPR applications for genotyping and mutation detection offers significant growth opportunities.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.64 billion |
Estimated Year [2024] | USD 6.20 billion |
Forecast Year [2030] | USD 11.25 billion |
CAGR (%) | 10.35% |
Product Type: Growing demand for high-throughput and precise quantification instruments
The instruments segment in the digital PCR market encompasses analyzers, PCR machines, and the thermocycler designed for the partitioning of samples into thousands, or even millions, of droplets, conducting PCR in each partition and then analyzing these droplets to determine the presence or quantity of genetic material. These instruments are essential for applications requiring high sensitivity, such as detecting rare alleles, quantifying viral load, and validating next-generation sequencing data. Reagents and consumables are critical in ensuring the efficiency, reliability, and reproducibility of digital PCR experiments. This category encompasses a broad range of products, including master mixes, fluorescence-labeled probes, and primers specifically optimized for digital PCR. Additionally, consumables such as microplates, chips, or cartridges are designed for single-use to prevent cross-contamination. The digital PCR services sector provides comprehensive support ranging from experimental design to data analysis, catering to researchers and laboratories lacking the resources or expertise to run digital PCR in-house. These services include assay design, sample preparation, and custom analysis.
Application: Higher significance of dPCR for disease detection and monitoring
In clinical research, dPCR is primarily employed for its high precision in quantification, sensitivity, and ability to detect low-level pathogens, minimal residual disease, and genetic variations. The reliability of dPCR makes it indispensable for liquid biopsy, infectious disease detection, and oncology studies. Digital PCR is used in blood screening for detecting minimal traces of genetic material in blood samples, thereby aiding in the early diagnosis and monitoring of diseases. dPCR in infectious disease testing offers a robust method for detecting and quantifying infectious pathogens, ensuring timely and accurate diagnosis of viral and bacterial infections. In oncology testing, dPCR enables the detection of cancer-associated mutations and the quantification of tumor DNA in blood, providing valuable insights for cancer diagnosis and treatment decisions. In the field of transplant diagnostics, dPCR facilitates the precise monitoring of donor organ DNA in transplant recipients' blood, which is critical for the early detection of transplant rejection and guiding immunosuppression therapy.
Digital PCR finds significant application in environmental monitoring owing to its accuracy in detecting and quantifying specific microbial and viral pathogens in water, soil, and air samples. Its capability to analyze complex environmental samples without the need for prior culturing positions dPCR as a critical tool for monitoring water quality, airborne pathogens, and soil health. Digital PCR is extensively applied in genetically modified organisms (GMOs) testing for its high precision in detecting and quantifying genetically modified sequences in crops and food products. Its high sensitivity allows for accurate GMO content determination, which is critical for labeling compliance and consumer safety.
Regional Insights
In the Americas, the adoption and implementation of digital PCR technology are primarily driven by the strong research infrastructure, the presence of major pharmaceutical and biotechnology companies, and substantial investments in healthcare and diagnostics. Investments in oncology research and the focus on infectious disease diagnostics have further propelled the demand for dPCR in the region, resulting in significant market growth within the global landscape. The EMEA region shows a diverse market adoption owing to varying economic, technological, and healthcare system strengths across different countries. Europe showcases higher adoption rates, driven by advancements in pharmaceutical and biotech research sectors, coupled with supportive government policies favoring genomic research. The Middle East and Africa, while growing, exhibit a slower adoption rate, mainly restrained by limited infrastructure and funding. However, increased investments in healthcare and growing awareness about advanced diagnostics solutions are expected to catalyze the dPCR market growth in these areas. Asia-Pacific is witnessing the fastest growth in the digital PCR market, attributed to rapidly developing healthcare infrastructures, rising investments in biotechnology and pharmaceutical research, and increasing focus on precision medicine. Additionally, the growing population and rising prevalence of chronic diseases have led to the adoption of advanced diagnostic technologies, including dPCR.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Digital PCR Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Digital PCR Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Digital PCR Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accumax, Agilent Technologies, Inc., Analytik Jena GmbH by Endress+Hauser, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, ELITechGroup by Bruker Corp., Eppendorf AG, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, JN MedSys, Merck Sharp & Dohme Corp., PerkinElmer, Inc., Precigenome LLC, Promega Corporation, Qiagen N.V., RainSure Scientific, Roche Holding AG, Stem Genomics, Stilla Technologies, Takara Bio, Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Digital PCR Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Digital PCR Market?
3. What are the technology trends and regulatory frameworks in the Digital PCR Market?
4. What is the market share of the leading vendors in the Digital PCR Market?
5. Which modes and strategic moves are suitable for entering the Digital PCR Market?